Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents.

Appl Clin Genet · 2011 · PMC3681176 · PMID 23776365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Despite being very well tolerated, with no participants discontinuing the treatment due to adverse effects, the primary end point of change in the 6-minute walk test failed to reach statistical significance during the trial.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.